SHOX2 and cancer: Several studies have concentrated on the detection of aberrant methylation of the SHOX2 and RASSF1A genes in plasma cfDNA as well as bronchoalveolar lavage fluid specimens to help improve the diagnosis of malignant tumors, while little attention has been given to cfDNA methylation in PE [31].